Azenta Inc (AZTA)
Azenta, Inc. is a NASDAQ-listed common stock issuer in the healthcare sector, focused on life sciences tools and services. The company provides solutions for the exploration and management of biological and chemical compound samples across markets in the United States, China, the United Kingdom, the rest of Europe, the Asia Pacific, and other international regions. Its operations are organized into two segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment includes automated storage systems, cryogenic equipment, automated sample tubes, consumables, instruments, controlled-rate thawing devices, repository services, and consulting support for experimental design and implementation. The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. Founded in 1978 and headquartered in Burlington, Massachusetts, the company adopted the Azenta name in December 2021 after previously operating as Brooks Automation, Inc. Azenta also maintains a strategic partnership with Frontier Space Ltd to support scientific experiments conducted in space.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AZTA
|
$34.13
|
27.0% Upside
|
Undervalued
|
$27.80
|
3.4% Upside
|
Fair
|
Good
|
—
|
—
|
—
|
0.0%
|
August 11, 2026
|
-11.2x
|
0.8x
|
2.1x
|
1.21 B
|
739.6 M
|
4.4%
|
88.1%
|
4.3
|
—
|
-27.1%
|